Shaffer Holly C, Parsons Daniel J, Peden David B, Morrell Dean
Department of Dermatology, University of North Carolina, Chapel Hill, NC 27599, USA.
J Am Acad Dermatol. 2006 May;54(5 Suppl):S210-3. doi: 10.1016/j.jaad.2005.06.012.
Mastocytosis refers to a rare collection of disorders, both cutaneous and systemic, that are characterized by increased numbers of mast cells. Depending on the extent of the disease, these disorders may present with symptoms resulting from mast cell degranulation including flushing, diarrhea, vomiting, cramping, syncope, or anaphylaxis. In pediatric patients, cutaneous involvement is most prevalent in the form of urticaria pigmentosa, which is typically asymptomatic or minimally so with resolution by adolescence. In this case report and review of literature, we review a case of a 3-year-old child with uritcaria pigmentosa displaying recurrent syncope and anaphylaxis as the first presentation of systemic mastocytosis. We found data to be limited on this topic, and concluded that pediatric patients with prior diagnoses of cutaneous mastocytosis could benefit from either more aggressive screening for systemic disease or prophylactic treatment with antihistamines and rescue subcutaneous epinephrine.
肥大细胞增多症是指一类罕见的疾病,包括皮肤型和系统型,其特征是肥大细胞数量增加。根据疾病的程度,这些疾病可能会出现因肥大细胞脱颗粒导致的症状,包括潮红、腹泻、呕吐、绞痛、晕厥或过敏反应。在儿科患者中,皮肤受累最常见的形式是色素性荨麻疹,通常无症状或症状轻微,到青春期可自行消退。在本病例报告及文献综述中,我们回顾了一例3岁色素性荨麻疹患儿,其首次表现为复发性晕厥和过敏反应,这是系统性肥大细胞增多症的表现。我们发现关于这个主题的数据有限,并得出结论,先前诊断为皮肤肥大细胞增多症的儿科患者可能会从更积极的系统性疾病筛查或使用抗组胺药及皮下注射肾上腺素进行预防性治疗中获益。